Abbott starts trial on deep brain stimulation for depressive disorder
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a.
Drugs
Health
Pharma
Drugs
Health
Pharma
EC approves Merck’s bladder cancer combination therapy in adults
Merck & Co., got approval from the European Commission to market its combination therapy to treat metastatic urothelial cancer or bladder cancer in.
Drugs
Health
Pharma
Cigarette smoking may help fight Parkinson’s disease: Harvard research
Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice.
Drugs
Health
Pharma
Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.
Drugs
Health
Pharma
Walgreens grabs $100 million from US government for decentralized trials
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million government funding to expand its clinical.
Drugs
Health
Pharma
‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.
Drugs
Health
Pharma
US regulator rejects Lykos’s MDMA therapy, wants more data
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.
Drugs
Health
Pharma
Merck halts small cell lung cancer immunotherapy drug trial
Merck has stopped an end-stage combination immunotherapy trial for a lung cancer condition, following recommendations of an independent data monitoring committee, which indicated.
Drugs
Health
Pharma
Daiichi Sankyo to pay Merck $170 million for cancer test drug rights
Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for.
Drugs
Health
Pharma
US regulator allows GSK’s endometrial cancer therapy for expanded use
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.